Get started
Author

Maria Palassopoulou

Observed names: M Palassopoulou, M. Palassopoulou, MARIA PALASSOPOULOU, Maria D. Palasopoulou, Maria Palasopoulou
ORCID: 0009-0004-7057-5405
Observed ORCID: 0009-0004-7057-5405
OpenAlex ID: A5083879904
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP
2021 · Theodoros P. Vassilakopoulos, Michail Michail, et al. · The Oncologist · 29
PDF
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies
2021 · Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, et al. · Annals of Hematology · 27
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
2017 · Maria K. Angelopoulou, Theodoros P. Vassilakopoulos, et al. · Hematological Oncology · 19
PDF
A Primary Hepatic Lymphoma Treated with Liver Resection and Chemotherapy
2014 · Konstantinos Bouliaris, Grigorios Christodoulidis, et al. · Case Reports in Surgery · 14
PDF
TACI Expression and Signaling in Chronic Lymphocytic Leukemia
2015 · Antigoni Mamara, Anastasios E. Germenis, et al. · Journal of Immunology Research · 11
PDF
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma
2022 · STAMATIS J. KARAKATSANIS, MARIA BOUZANI, et al. · In Vivo · 10
PDF
Abstracts from the 10th C1-inhibitor deficiency workshop
2017 · on behalf of COMPACT investigators, Alvin H. Schmaier, et al. · Allergy Asthma and Clinical Immunology · 9
PDF
Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ
2023 · Elena E. Solomou, Antonis Kattamis, et al. · Blood Advances · 8
Metabolism-Related Cytokine and Hormone Levels in the Serum of Patients with Myelodysplastic Syndromes
2013 · Eleni Bouronikou, Panagiotis Georgoulias, et al. · Acta Haematologica · 8
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?
2023 · Theodoros P. Vassilakopoulos, Alexia Piperidou, et al. · HemaSphere · 7
BAFF/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner
2019 · Eirini Sevdali, Eleni Katsantoni, et al. · Frontiers in Oncology · 5
PDF
Successful Control of Acute Myelofibrosis with Lenalidomide
2010 · G. Vassilopoulos, M. Palassopoulou, et al. · Case Reports in Medicine · 5
PDF
Rituximab‐dose‐adjusted Epoch (r‐da‐epoch) in Primary Mediastinal Large B‐cell Lymphoma (pmlbcl): Real‐life Experience on 190 Patients From 3 Mediterranean Countries
2021 · T. Vassilakopoulos, B. Ferhanoglu, et al. · Hematological Oncology · 4
PDF
Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase+dim acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures
2011 · Nikolaos C. Giannakoulas, Evangelos Terpos, et al. · Leukemia Research · 3
REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS
2023 · T. Vassilakopoulos, B. Ferhanoglu, et al. · Hematological Oncology · 2
PDF
Multiple Autoimmune Propensity and B-Non-Hodgkin Lymphoma: Cause or Effect?
2011 · E. Koumati, M. Palassopoulou, et al. · Autoimmune Diseases · 2
PDF
P1229: Rituximab-dose-adjusted Epoch (r-da-epoch) in Primary Mediastinal Large B-cell Lymphoma (pmlbcl): Real-life Experience on 225 Patients From 4 Countries
2022 · T. Vassilakopoulos, B. Ferhanoglu, et al. · HemaSphere · 1
Increased Age-Related B-Cells in Patients with Aplastic Anemia
2018 · Elena E. Solomou, Eva Plakoula, et al. · Blood · 1
Ruxolitinib Efficacy and Safety in Myelofibrosis: A Multicenter Observational Study
2015 · Damianos Sotiropoulos, Vassilios Papadopoulos, et al. · Blood · 1
TNFRSF13B/TACI and TNFRSF13C/BAFFR in B cell chronic lymphocytic leukemia (B-CLL)
2012 · Antigoni Mamara, Fani Kalala, et al. · University of Thessaly Institutional Repository (University of Thessaly) · 1
Anemia in a Cohort of Greek Patients with Sickle Cell Disease: Clinical Insights and Therapeutic Challenges
2026 · Michael D. Diamantidis, Ioanna Argyrakouli, et al. · Hematology Reports
344 | SERUM β2‐ MICROGLOBULIN LEVELS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: AN UNRECOGNIZED PROGNOSTIC FACTOR
2025 · T. Vassilakopoulos, M. Arapaki, et al. · Hematological Oncology
PDF
346 | Rituximab‐dose‐adjusted Epoch Versus Rituximab‐chop in Primary Mediastinal Large B‐cell Lymphoma
2025 · T. Vassilakopoulos, Z. Mellios, et al. · Hematological Oncology
PDF
P1121: Positron Emission Tomography for Final Response Assessment to Rituximab-dose Adjusted Epoch in Primary Mediastinal Large B-cell Lymphoma: Who Is Worthy to Be Irradiated?
2023 · Theodoros Vassilakopoulos, Alexia Piperidou, et al. · HemaSphere
P1178: the Applicability of Prognostic Models Under Rituximab-dose-adjusted Epoch (r-da-epoch) in Primary Mediastinal Large B-cell Lymphoma (pmlbcl): a Comparison With R-chop
2023 · Theodoros Vassilakopoulos, B Ferhanoglu, et al. · HemaSphere
Works count: 30
Citation count: 167
H-index: 8
I10-index: 6
Year
Topic
Type